- Status:
- Awaiting development
- Technology type:
- Medicine
- Decision:
- Selected
- Prioritisation programme:
- Medicines evaluation
- Rationale:
- Criteria within the 2024 Voluntary Scheme for Pricing, Access and Growth (VPAG) met as a significant licence extension.
- Process:
- STA Standard
- ID number:
- 6690
Project Team
- Project lead
- Rebecca Richardson
Email enquiries
If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 15 December 2025 | Awaiting development. Status change linked to topic prioritisation decision being set to Selected |
For further information on our processes and methods, please see our CHTE processes and methods manual